Patent details

Basic Information

Publication number:

EP3791862

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Unitary Effect Registered

Application number:

EP202052502

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

LIQUID PROTEIN FORMULATIONS CONTAINING VISCOSITY-LOWERING AGENTS

French Title of Invention:

FORMULATIONS DE PROTÉINES LIQUIDES CONTENANT DES AGENTS ABAISSANT LA VISCOSITÉ

German Title of Invention:

FLÜSSIGE PROTEINFORMULIERUNGEN MIT VISKOSITÄTSSENKENDEN MITTELN

SPC Number:

Unitary Effect

Unitary Effect Requested:

Yes

Unitary Effect Request Filing Date:

01/07/2024

Link to UPP Register:

European Patent Register

Unitary Effect Request Withdrawal Date:

Unitary Effect Status:

Unitary Effect Registered

Unitary Effect Acceptance Decision Date:

02/09/2024

Unitary Effect Rejection Decision Date:

Unitary Effect Date:

29/05/2024

Unitary Effect Registration Date:

02/09/2024

Unitary Effect Re-establishment of rights Filing Date:

Unitary Effect Re-establishment of rights EPO Decision :

Unitary Effect Re-establishment of rights EPO Decision Date:

Explanatory Text UE:

Safety Net Request Date:

Safety Net Decision Date:

Safety Net Decision Outcome:

SPC Number:

Dates

Filing date:

11/09/2014

Grant date:

29/05/2024

EP Publication Date:

17/03/2021

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/05/2024

EP B1 Publication Date:

29/05/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

11/09/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/05/2024

 

 

Name:

Eagle Biologics, Inc.

Address:

47 Moulton Street, Cambridge, MA 02138, United States (US)

Inventor

1

Name:

WEIGHT, Alisha K.

Address:

United States (US)

2

Name:

LOVE, Kevin

Address:

United States (US)

3

Name:

CRANE, Alan

Address:

United States (US)

4

Name:

LARSON, Alyssa M.

Address:

United States (US)

5

Name:

LANGER, Robert S.

Address:

United States (US)

6

Name:

KLIBANOV, Alexander M.

Address:

United States (US)

Priority

1

Priority Number:

201361876621 P

Priority Date:

11/09/2013

Priority Country:

United States (US)

2

Priority Number:

201461940227 P

Priority Date:

14/02/2014

Priority Country:

United States (US)

3

Priority Number:

201461943197 P

Priority Date:

21/02/2014

Priority Country:

United States (US)

4

Priority Number:

201461946436 P

Priority Date:

28/02/2014

Priority Country:

United States (US)

5

Priority Number:

201461988005 P

Priority Date:

02/05/2014

Priority Country:

United States (US)

6

Priority Number:

201462008050 P

Priority Date:

05/06/2014

Priority Country:

United States (US)

7

Priority Number:

201462026497 P

Priority Date:

18/07/2014

Priority Country:

United States (US)

8

Priority Number:

201462030521 P

Priority Date:

29/07/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/08; A61K 47/18; A61K 39/395; C07K 1/14; A61K 9/00; A61K 39/00; A61K 9/19; A61K 38/00; A61K 47/20;

Publication

European Patent Bulletin

1

Issue number:

202422

Publication date:

29/05/2024

Description:

Grant (B1)

2

Issue number:

202428

Publication date:

10/07/2024

Description:

Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:

202432

Publication date:

07/08/2024

Description:

Unitary Effect Request Receipt

4

Issue number:

202440

Publication date:

02/10/2024

Description:

Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages